AGIC Capital acquires majority stake in ATEC Pharmatechnik

AGIC Capital acquired a majority stake in ATEC Pharmatechnik GmbH, a manufacturer of aseptic processing solutions for pharmaceutical and bioprocessing applications. The sellers, founder Hans-Werner Mumm and HANNOVER Finanz Group, will retain a stake, and Mumm will continue as CEO.

“AGIC Capital today announced that it had acquired a majority stake in ATEC Pharmatechnik GmbH.”sttinfo.fi

• 2 sources
• sttinfo.fiAGIC Capital Acquires Majority Stake in ATEC Pharmatechnik GmbH | Business WireNov 30, 2022
• biospace.comAGIC Capital Acquires Majority Stake in ATEC Pharmatechnik GmbH - BioSpaceGabrielle MassonNov 30, 2022

Summarized from public sources; check the original articles before acting on it.